These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33187852)

  • 1. Successful Antithrombin Administration in Andexanet Alfa-Associated Heparin Resistance.
    Apostel HJCL; Winckers K; Bidar E; Schreiber JU
    J Cardiothorac Vasc Anesth; 2021 Mar; 35(3):904-907. PubMed ID: 33187852
    [No Abstract]   [Full Text] [Related]  

  • 2. Antithrombin supplementation attenuates heparin resistance in plasma spiked with Gla-domainless factor Xa S195A in vitro.
    Mishima Y; Butt AL; Vandyck KB; Levy JH; Stewart KE; Tanaka KA
    Br J Anaesth; 2024 Jun; 132(6):1204-1210. PubMed ID: 38594117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Heparin Resistance After Administration of Andexanet Alfa:Report of a Case].
    Aratame A; Baba T; Minamimura H; Nishimoto Y; Nangoya R
    Kyobu Geka; 2024 Jun; 77(6):454-456. PubMed ID: 39009541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiopulmonary Bypass Circuit Obstruction and Urgent Replacement After the Administration of Andexanet Alfa.
    Nozumi Y; Yonezawa Y; Yunoki K; Mima H
    J Cardiothorac Vasc Anesth; 2024 Mar; 38(3):780-783. PubMed ID: 38148268
    [No Abstract]   [Full Text] [Related]  

  • 5. Andexanet Alfa-Induced Heparin Resistance: Sustained Anticoagulant Inefficacy Despite Antithrombin Therapy.
    Nagashima K; Ueki C; Numari J; Yamaki N; Yamamoto T; Matsuyama S
    J Cardiothorac Vasc Anesth; 2024 Aug; 38(8):1727-1729. PubMed ID: 38834448
    [No Abstract]   [Full Text] [Related]  

  • 6. Andexanet alpha-induced heparin resistance treated by nafamostat mesylate in a patient undergoing total aortic arch repair for Stanford type A acute aortic dissection: a case report.
    Suzuki Y; Kikura M; Kawashima S; Kimura T; Nakajima Y
    JA Clin Rep; 2024 Jan; 10(1):6. PubMed ID: 38285208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Andexanet Alfa-Induced Heparin Resistance: When Anticoagulation Really Remains Reversed.
    Erdoes G; Birschmann I; Nagler M; Koster A
    J Cardiothorac Vasc Anesth; 2021 Mar; 35(3):908-909. PubMed ID: 33339660
    [No Abstract]   [Full Text] [Related]  

  • 8. Andexanet Alfa for Urgent Reversal of Apixaban Before Aortic Surgery Requiring Cardiopulmonary Bypass: A Case Report.
    Flaherty D; Connors JM; Singh S; Sylvester KW; Rimsans J; Cornella L
    A A Pract; 2019 Oct; 13(7):271-273. PubMed ID: 31265446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful Nafamostat Mesilate Administration for Andexanet Alfa-Induced Heparin Resistance.
    Kitaura A; Iwamoto T; Hamasaki S; Tsukimoto S; Nakajima Y
    Cureus; 2023 Aug; 15(8):e44003. PubMed ID: 37746371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Andexanet-Alfa-Associated Heparin Resistance in the Context of Hemorrhagic Stroke.
    Müther M; Schwindt W; Mesters RM; Minnerup J; Stracke P; Holling M; Wiendl H; Stummer W
    Neurocrit Care; 2022 Oct; 37(2):372-376. PubMed ID: 35931915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating heparin resistance with antithrombin or fresh frozen plasma.
    Spiess BD
    Ann Thorac Surg; 2008 Jun; 85(6):2153-60. PubMed ID: 18498854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assay-Based Differentiation in the Neutralization Profile of Unfractionated Heparin, Enoxaparin, and Fondaparinux by Andexanet Alfa.
    Siddiqui F; Tafur A; Bontekoe E; Iqbal O; Jeske W; Mehrotra S; Hoppensteadt D; Ramacciotti E; Fareed J
    Clin Appl Thromb Hemost; 2020; 26():1076029619895120. PubMed ID: 31914798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Andexanet alfa to reverse the anticoagulant activity of factor Xa inhibitors: a review of design, development and potential place in therapy.
    Sartori M; Cosmi B
    J Thromb Thrombolysis; 2018 Apr; 45(3):345-352. PubMed ID: 29372400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraoperative Unfractionated Heparin Unresponsiveness during Endovascular Repair of a Ruptured Abdominal Aortic Aneurysm following Administration of Andexanet Alfa for the Reversal of Rivaroxaban.
    Eche IM; Elsamadisi P; Wex N; Wyers MC; Brat GA; Cunningham K; Bauer KA
    Pharmacotherapy; 2019 Aug; 39(8):861-865. PubMed ID: 31251821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Andexanet alfa-associated heparin resistance in cardiac surgery: mechanism and
    Chabata CV; Yu H; Ke L; Frederiksen JW; Patel PA; Sullenger BA; Thalji NK
    bioRxiv; 2024 Sep; ():. PubMed ID: 39314402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Andexanet alfa: A Novel Factor Xa Inhibitor Reversal Agent.
    Powell J; Taylor J; Garland SG
    Ann Pharmacother; 2019 Sep; 53(9):940-946. PubMed ID: 30813754
    [No Abstract]   [Full Text] [Related]  

  • 17. Andexanet alfa in acute aortic syndrome: first UK experience.
    Al-Attar N; Sedeek AF; McCall P; Travers J
    Eur J Cardiothorac Surg; 2023 Jun; 63(6):. PubMed ID: 36943384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
    Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
    Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Andexanet Alfa, the Possible Alternative to Protamine for Reversal of Unfractionated Heparin.
    Maneno JN; Ness GL
    Ann Pharmacother; 2021 Feb; 55(2):261-264. PubMed ID: 32667214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Andexanet Alfa (Andexxa) Formulary Review.
    Beik N; Reddy P; Sylvester KW; Connell NT; Giugliano RP; Piazza G; Connors JM
    Crit Pathw Cardiol; 2019 Jun; 18(2):66-71. PubMed ID: 31094731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.